Hydrogen peroxide preconditioning protects PC12 cells against apoptosis induced by dopamine

被引:25
作者
Tang, XQ
Zhi, JL
Cui, Y
Feng, JQ [1 ]
Chen, PX
机构
[1] Sun Yat Sen Univ, Zhongshan Med Coll, Dept Physiol, Guangzhou 510080, Peoples R China
[2] Nahua Univ, Coll Med, Dept Physiol, Hengyang City 421001, Hunan Province, Peoples R China
关键词
hydrogen peroxide; preconditioning dopamine; apoptosis; PC12; cells; Parkinson's disease;
D O I
10.1016/j.lfs.2005.04.048
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Dopamine (DA), one of the major sources of reactive oxygen species (ROS), is implicated in neuronal death associated with Parkinson's disease (PD). Preconditioning with oxidative stress has been shown to provide cytoprotection similar to ischemic Preconditioning (IPC), against cell apoptosis. In this study, using the model neurosecretory cell line, PC12, we investigated whether hydrogen peroxide (H2O2) at low concentration (10 mu M) can protect PC12 cells against apoptosis induced by DA. PC12 cells were preconditioned with 10 mu M H2O2 for 90 min, followed by 24-h recovery and subsequent exposures to different concentrations (20, 50 100 and 200 mu M) of DA for 24-h, respectively. DA induced apoptotic cell death with significant morphological nuclear changes and DNA fragmentation as well as the dysfunction of mitochondria. Preconditioning with H2O2 at 10 mu M significantly reduced the percentage of apoptotic cells and partly blocked the decreases in 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) reduction and mitochondrial membrane potential (MMP) induced by DA. These results suggest that preconditioning with low concentration of H2O2 protected PC12 cells against DAinduced apoptosis, the part restoration of the damaged mitochondrial functions might be one of the underlying mechanisms of this cytoprotection. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:61 / 66
页数:6
相关论文
共 20 条
[1]   Mechanistically distinct steps in the mitochondrial death pathway triggered by oxidative stress in cardiac myocytes [J].
Akao, M ;
O'Rourke, B ;
Teshima, Y ;
Seharaseyon, J ;
Marbán, E .
CIRCULATION RESEARCH, 2003, 92 (02) :186-194
[2]   Pathophysiology of Parkinson's disease [J].
Bonnet, AM ;
Houeto, JL .
BIOMEDICINE & PHARMACOTHERAPY, 1999, 53 (03) :117-121
[3]  
Cohen G, 1983, J Neural Transm Suppl, V19, P89
[4]  
GRAHAM DG, 1978, MOL PHARMACOL, V14, P644
[5]   ANTIOXIDANT THERAPY IN PARKINSONS-DISEASE [J].
GRIMES, JD ;
HASSAN, MN ;
THAKAR, J .
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1987, 14 (03) :483-487
[6]   REACTIVE OXYGEN SPECIES AND THE CENTRAL-NERVOUS-SYSTEM [J].
HALLIWELL, B .
JOURNAL OF NEUROCHEMISTRY, 1992, 59 (05) :1609-1623
[7]   Oxidative preconditioning and apoptosis in L-cells - Roles of protein kinase B and mitogen-activated protein kinases [J].
Han, H ;
Wang, HZ ;
Long, H ;
Nattel, S ;
Wang, ZG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (28) :26357-26364
[8]   Apoptosis-inducing neurotoxicity of dopamine and its metabolites via reactive quinone generation in neuroblastoma cells [J].
Haque, ME ;
Asanuma, M ;
Higashi, Y ;
Miyazaki, I ;
Tanaka, K ;
Ogawa, N .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2003, 1619 (01) :39-52
[9]  
HASTINGS TG, 1995, J NEUROCHEM, V64, P919
[10]   DOES OXIDATIVE STRESS PARTICIPATE IN NERVE-CELL DEATH IN PARKINSONS-DISEASE [J].
HIRSCH, EC .
EUROPEAN NEUROLOGY, 1993, 33 :52-59